The stock of Applied DNA Sciences Inc (NASDAQ:APDN) hit a new 52-week low and has $1.98 target or 12.00% below today’s $2.25 share price. The 8 months bearish chart indicates high risk for the $54.18 million company. The 1-year low was reported on Nov, 3 by Barchart.com. If the $1.98 price target is reached, the company will be worth $6.50M less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. About 138,918 shares traded hands or 288.68% up from the average. Applied DNA Sciences Inc (NASDAQ:APDN) has declined 23.30% since April 1, 2016 and is downtrending. It has underperformed by 24.52% the S&P500.
Analysts await Applied DNA Sciences Inc (NASDAQ:APDN) to report earnings on December, 12. They expect $-0.06 EPS, down 200.00% or $0.04 from last year’s $-0.02 per share. After $-0.14 actual EPS reported by Applied DNA Sciences Inc for the previous quarter, Wall Street now forecasts -57.14% EPS growth.
According to Zacks Investment Research, “Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion. They develop, market, and sub-license DNA security systems, supply-chain management systems and anti-counterfeit solutions. Applied DNA Sciences has an exclusive licensing and partnership agreement covering North America and Europe with Biowell Technology, Inc. of Taiwan.”
Insitutional Activity: The institutional sentiment increased to 1.44 in 2016 Q2. Its up 0.08, from 1.36 in 2016Q1. The ratio improved, as 7 funds sold all Applied DNA Sciences Inc shares owned while 2 reduced positions. 4 funds bought stakes while 9 increased positions. They now own 1.65 million shares or 1.88% less from 1.68 million shares in 2016Q1.
Vanguard Group Inc has invested 0% of its portfolio in Applied DNA Sciences Inc (NASDAQ:APDN). Deutsche Savings Bank Ag, a Germany-based fund reported 1,494 shares. Gluskin Sheff And Associates Inc holds 0.01% of its portfolio in Applied DNA Sciences Inc (NASDAQ:APDN) for 20,000 shares. The Nebraska-based Cwm Ltd Com has invested 0% in Applied DNA Sciences Inc (NASDAQ:APDN). Oppenheimer And accumulated 14,275 shares or 0% of the stock. Benchmark Cap holds 0.39% or 150,000 shares in its portfolio. Northern Tru Corp last reported 33,086 shares in the company. Blackrock Fund Advsr reported 56,917 shares or 0% of all its holdings. Dumont Blake Invest Advsrs Lc last reported 0.04% of its portfolio in the stock. Morgan Stanley holds 0% of its portfolio in Applied DNA Sciences Inc (NASDAQ:APDN) for 112,160 shares. California Public Employees Retirement holds 0% or 36,200 shares in its portfolio. Blackrock Inv Management Ltd Liability Corporation reported 3,451 shares or 0% of all its holdings. Moreover, Bank Of America De has 0% invested in Applied DNA Sciences Inc (NASDAQ:APDN) for 46,002 shares. Geode Capital Mngmt Ltd Company owns 84,126 shares or 0% of their US portfolio. Blackrock Institutional Company Na accumulated 0% or 145,795 shares.
More notable recent Applied DNA Sciences Inc (NASDAQ:APDN) news were published by: Marketwatch.com which released: “Applied DNA Sciences Announces $5 Million Private Placement” on November 02, 2016, also Marketwatch.com with their article: “Applied DNA Sciences Announces $8.75 Million Registered Direct Offering” published on November 23, 2015, Thestreet.com published: “Applied DNA Sciences Is Surging in Antitheft, Fraud Prevention Business” on September 28, 2015. More interesting news about Applied DNA Sciences Inc (NASDAQ:APDN) were released by: Streetinsider.com and their article: “Applied DNA Sciences (APDN) Enters Agreement with Document Authentication …” published on July 07, 2016 as well as Marketwired.com‘s news article titled: “Applied DNA Sciences Inc. Announces Uplisting to NASDAQ and Pricing of $9.1 …” with publication date: November 17, 2014.
APDN Company Profile
Applied DNA Sciences, Inc., incorporated on December 17, 2008, provides plant deoxyribonucleic acid (DNA) security, and authentication solutions and services that help protect products, brands, supply chains and intellectual property of companies, governments and clients from theft, counterfeiting, fraud and diversion. The Firm is also engaged in the production of specific DNA sequences using the polymerase chain reaction (PCR). The Company’s product solutions are SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, Sentry, digitalDNA and SmokeCloak DNA, among others. The Company’s product solutions are used in various industries, including microcircuits and other electronics, cash-in-transit (transport and storage of banknotes), textiles and apparel, home asset marking, automotive, printing and packaging, homeland security, law enforcement, identity cards and other secure documents, industrial materials, agrochemicals, pharmaceuticals, consumer products, food and beverage, fine wine, and art and collectibles.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.